Jack Bartram

Enhanced CAR T cell expansion and prolonged persistence in pediatric patients with ALL treated with a low-affinity CD19 CAR

Sara Ghorashian, Anne Marijn Kramer, Shimobi Onuoha et al. · Nature Medicine · 2019 · 613 citations

Cell Therapy, Prolonged Persistence, Autoimmune Disease +9

Genotype-Specific Minimal Residual Disease Interpretation Improves Stratification in Pediatric Acute Lymphoblastic Leukemia

David O’Connor, Amir Enshaei, Jack Bartram et al. · Journal of Clinical Oncology · 2017 · 164 citations · Full text

Targeting acute myeloid leukemia by drug-induced c-MYB degradation

Vanessa Walf-Vorderwülbecke, Kerra Pearce, Tony Brooks et al. · Leukemia · 2017 · 114 citations

Hematological Malignancy, Medicine, Acute Myeloid Leukemia +5

Use of Minimal Residual Disease Assessment to Redefine Induction Failure in Pediatric Acute Lymphoblastic Leukemia

David O’Connor, Anthony V. Moorman, Rachel Wade et al. · Journal of Clinical Oncology · 2017 · 83 citations · Full text

Hematological Malignancy, Residual Disease, Prognostic Evaluation +14

Persistent defective membrane trafficking in epithelial cells of patients with familial hemophagocytic lymphohistiocytosis type 5 due to <i>STXBP2/MUNC18‐2</i> mutations

Polina Stepensky, Jack Bartram, Thomas F.E. Barth et al. · Pediatric Blood & Cancer · 2013 · 71 citations